Phase I trial of biweekly Carboplatin plus nab-Paclitaxel with concurrent thoracic radiotherapy in patients with locally advanced non-small cell lung cancer
Phase of Trial: Phase I
Latest Information Update: 12 May 2016
At a glance
- Drugs Paclitaxel (Primary) ; Carboplatin
- Indications Non-small cell lung cancer
- Focus Adverse reactions
- 15 Jul 2015 Status is changed from recruiting to completed as per results published in ASCO 2015
- 02 Jun 2015 Results presented at the 51st Annual Meeting of the American Society of Clinical Oncology.
- 18 May 2013 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.